8月17日，2025年健康产业生态大会（西普会）在海南博鳌正式拉开帷幕。这场以"快蜕变，穿越新周 期"为主题的医药行业年度盛会，吸引了超千家企业齐聚，共同探索产业转型与增长路径。深耕皮肤外 用药领域的浙江孚诺医药股份有限公司，携王牌产品孚诺 软膏（孚诺复方多黏菌素B软膏）亮相亚洲论 坛大酒店展览区P02展位，其"伤口愈合快"的产品实力与清晰的零售渠道战略，成为开幕首日焦点，为 零售渠道注入新动能。 紧扣行业脉搏，孚诺零售战略引关注 作为中国医药产业的"风向标"，本届西普会紧扣行业变革脉搏。在医药分家深化、消费健康需求升级的 背景下，"如何从院端优势向零售市场延伸"成为全场热议的核心命题之一。而孚诺医药此次参展，正是 带着"解锁药店增长新机遇"的明确战略而来。 开幕当天上午，P02展位前便排起咨询长队。"我们关注孚诺很久了，知道它在医院端的口碑，现在听说 正式做零售，特意来了解合作细节。"来自华东地区的连锁药店采购负责人手持资料说道。现场工作人 员介绍，孚诺选择在西普会共探零售渠道，正是看中大会作为"产业连接器"的价值，希望借助这一平台 与全国合作伙伴建立深度链接。 能在零售渠道布局初期便获关注，源于孚诺 软膏 ...

Core Insights - The article highlights the importance of patents in measuring the innovation capability of companies in the pharmaceutical sector, specifically focusing on Funo Pharmaceutical's eight invention patents that cover critical areas such as drug preparation methods and new drug components [2][4]. Group 1: Patent and Innovation - Funo Pharmaceutical has developed eight invention patents, including methods for preparing Sulfate Polymyxin B and fermentation processes for Sulfate Neomycin, leading to the creation of the Chinese version of the Triple Antibiotic Ointment [2][4]. - The patented formulation has demonstrated a 34% increase in wound healing speed, showcasing the company's technological advantages in core ingredient purification and production [2][4]. Group 2: Market Position and Sales - Funo Pharmaceutical's compound Polymyxin B ointment has maintained the top sales position in China's hospital and outpatient antibiotic market for nine consecutive years, with annual sales exceeding 440 million yuan, which translates to an average of one unit sold every two seconds [4][5]. - The company has established three major R&D platforms in collaboration with top institutions, enhancing its competitive edge in the skin topical medication market [4]. Group 3: Brand Strategy and Consumer Engagement - Funo Pharmaceutical employs a dual-track strategy to enhance product strength and brand development, focusing on the efficacy of its core product, Funo Ointment, which combines three antibiotics for rapid bacterial elimination and wound healing [5][7]. - The company actively engages in brand communication to address public misconceptions about wound treatment, launching initiatives like the "Wound Healing Week" to raise awareness and promote its product's benefits [7][9]. Group 4: Recognition and Achievements - Funo Pharmaceutical has received numerous certifications and honors, including recognition as a top growth technology company and various provincial accolades, reflecting its technological depth and industry acknowledgment [7][9].